Penserra Capital Management LLC Ardelyx, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.86 - $1.7 $2,033 - $4,020	-2,365 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $152 - $980	120 Added 5.35%	2,365 $3,000
Q2 2021 Aug 12, 2021	BUY	$6.55 - $8.98 $1,244 - $1,706	190 Added 9.25%	2,245 $17,000
Q1 2021 May 13, 2021	SELL	$6.1 - $7.69 $91 - $115	-15 Reduced 0.72%	2,055 $13,000
Q4 2020 Feb 12, 2021	BUY	$5.05 - $7.1 $6,615 - $9,301	1,310 Added 172.37%	2,070 $13,000
Q3 2020 Nov 13, 2020	BUY	$5.25 - $7.08 $3,990 - $5,380	760 New	760 $3,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.